These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16928295)

  • 1. [Prognostic analysis of chronic myeloid leukemia with Cox model and the Sokal, Hasford score].
    Gan DY; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):662-6. PubMed ID: 16928295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EUTOS CML prognostic scoring system predicts ELN-based 'event-free survival' better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate.
    Uz B; Buyukasik Y; Atay H; Kelkitli E; Turgut M; Bektas O; Eliacik E; Isik A; Aksu S; Goker H; Sayinalp N; Ozcebe OI; Haznedaroglu IC
    Hematology; 2013 Sep; 18(5):247-52. PubMed ID: 23540886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage, percentage of basophils at diagnosis, hematologic response within six months, cytogenetic response in the first year: the main prognostic variables affecting outcome in patients with chronic myeloid leukemia in chronic phase treated with interferon-alpha. Results of the CML89 trial of the Spanish Collaborative Group on interferon-alpha2a and CML.
    Steegmann JL; Odriozola J; Rodriguez-Salvanés F; Giraldo P; García-Laraña J; Ferro MT; Benítez E; Pérez-Pons C; Giralt M; Escribano L; Lavilla E; Miguel A; Areal C; Pérez-Encinas M; Abad A; Maldonado J; Massagué I; Fernández-Rañada JM
    Haematologica; 1999 Nov; 84(11):978-87. PubMed ID: 10553157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of Hasford score and Sokal index in prognostication of the novo chronic myeloid leukemia patients and a search for new prognostic markers.
    Sinha SK; Sinha S; Mandal PK; Bhattacharyya NK; Pandey A; Gupta P
    Indian J Pathol Microbiol; 2013; 56(3):216-20. PubMed ID: 24152497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of Sokal, Hasford and EUTOS prognostic scoring systems in chronic myeloid leukemia].
    Feng G; Wang J; Jiang Y; Li Y; Ding M; Wang N; Wang X
    Zhonghua Xue Ye Xue Za Zhi; 2014 Aug; 35(8):743-6. PubMed ID: 25152126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retrospective cohort study on the prognosis of chronic myeloid leukemia].
    Liang X; Lin G; Zhang W; Shen Y; Tang Z; Wu W
    Zhonghua Nei Ke Za Zhi; 2000 Dec; 39(12):835-7. PubMed ID: 11798548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multivariate analysis of prognostic factors in Philadelphia chromosome-positive chronic granulocytic leukemia].
    Hao C; Wang Y; Li Q; Liu B; Qian L
    Zhonghua Xue Ye Xue Za Zhi; 2001 Jan; 22(1):5-8. PubMed ID: 11877041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon alpha and hydroxyurea.
    Hehlmann R; Berger U; Pfirrmann M; Hochhaus A; Metzgeroth G; Maywald O; Hasford J; Reiter A; Hossfeld DK; Kolb HJ; Löffler H; Pralle H; Queisser W; Griesshammer M; Nerl C; Kuse R; Tobler A; Eimermacher H; Tichelli A; Aul C; Wilhelm M; Fischer JT; Perker M; Scheid C; Schenk M; Weiss J; Meier CR; Kremers S; Labedzki L; Schmeiser T; Lohrmann HP; Heimpel H;
    Leukemia; 2003 Aug; 17(8):1529-37. PubMed ID: 12886239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors Affecting Early Molecular Response in Chronic Myeloid Leukemia.
    Chikkodi SV; Malhotra P; Naseem S; Khadwal A; Prakash G; Sahu KK; Kumari S; Suri V; Varma N; Varma S
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S114-9. PubMed ID: 26297263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing Sokal's and the new prognostic score for chronic myeloid leukaemia treated with alpha-interferon. Italian Cooperative Study Group on Chronic Myeloid Leukaemia.
    Bonifazi F; De Vivo A; Rosti G; Tiribelli M; Russo D; Trabacchi E; Fiacchini M; Montefusco E; Baccarani M
    Br J Haematol; 2000 Nov; 111(2):587-95. PubMed ID: 11122107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can prognostic scoring systems for chronic myeloid leukemia as established in adults be applied to pediatric patients?
    Gurrea Salas D; Glauche I; Tauer JT; Thiede C; Suttorp M
    Ann Hematol; 2015 Aug; 94(8):1363-71. PubMed ID: 25894600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation and extension of the EBMT Risk Score for patients with chronic myeloid leukaemia (CML) receiving allogeneic haematopoietic stem cell transplants.
    Passweg JR; Walker I; Sobocinski KA; Klein JP; Horowitz MM; Giralt SA;
    Br J Haematol; 2004 Jun; 125(5):613-20. PubMed ID: 15147377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up results.
    Kantarjian HM; Talpaz M; O'Brien S; Smith TL; Giles FJ; Faderl S; Thomas DA; Garcia-Manero G; Issa JP; Andreeff M; Kornblau SM; Koller C; Beran M; Keating M; Rios MB; Shan J; Resta D; Capdeville R; Hayes K; Albitar M; Freireich EJ; Cortes JE
    Clin Cancer Res; 2002 Jul; 8(7):2177-87. PubMed ID: 12114418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment and Survival in Patients with Chronic Myeloid Leukemia in a Chronic Phase in West Iran.
    Payandeh M; Sadeghi M; Sadeghi E
    Asian Pac J Cancer Prev; 2015; 16(17):7555-9. PubMed ID: 26625761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the impact of imatinib mesylate therapy on the prognosis of patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha regimens for early chronic phase.
    Kantarjian H; O'Brien S; Cortes J; Shan J; Giles F; Garcia-Manero G; Verstovsek S; Faderl S; Rios MB; Talpaz M
    Cancer; 2003 Oct; 98(7):1430-7. PubMed ID: 14508830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multivariate analysis of prognostic factors influencing survival in chronic myelogenous leukemia].
    Sakamoto S; Kurata H; Miwa A
    Rinsho Ketsueki; 1989 Aug; 30(8):1180-4. PubMed ID: 2601030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of three prognostic scoring systems on evaluating the prognosis for patients with chronic myeloid leukemia].
    Huang J; Zhao X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 41(8):809-14. PubMed ID: 27600007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Hasford Score May Predict Molecular Response in Chronic Myeloid Leukemia Patients: A Single Institution Experience.
    Dybko J; Jaźwiec B; Haus O; Urbaniak-Kujda D; Kapelko-Słowik K; Wróbel T; Lonc T; Sawicki M; Mędraś E; Kaczmar-Dybko A; Kuliczkowski K
    Dis Markers; 2016; 2016():7531472. PubMed ID: 27818567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Charlson comorbidity index predicts poor outcome in CML patients treated with tyrosine kinase inhibitor.
    Uemura M; Imataki O; Kawachi Y; Kawakami K; Hoshijima Y; Matsuoka A; Kadowaki N
    Int J Hematol; 2016 Nov; 104(5):621-627. PubMed ID: 27492732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term survival in chronic myeloid leukemia: frequency and fundamental characteristics in a series of 100 patients].
    Cervantes F; Bosch F; Terol MJ; Pereira A; Rozman C
    Sangre (Barc); 1993 Apr; 38(2):93-6. PubMed ID: 8516734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.